A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Clinical trial NCT07428616 · RECRUITING
Trial details
- NCT number
- NCT07428616
- Sponsor
- Exelixis
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-21
- Primary completion
- 2028-02-29
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.